article thumbnail

STAT Virtual Event | Tomorrow’s Trailblazers in Science

STAT

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers.

105
105
article thumbnail

Understanding Adverse Events With BCMA-, Non-BCMA-Targeting Bispecific Antibodies in Multiple Myeloma

Drug Topics

Understanding the adverse event profile of bispecific antibodies can aid treatment selection and improve patient outcomes.

200
200
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Virtual Event: March of the Biosimilars

STAT

Editor’s note: A livestream of this event will be embedded below at 1 p.m. Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines?

article thumbnail

STAT Virtual Event | Cancer’s Breakthrough Engine

STAT

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Since the development of Gleevec two decades ago, precision cancer medicines have become a driving force in biotech and a source of hope for cancer patients. Read the rest…

118
118
article thumbnail

STAT Virtual Event | 2024 JPM Recap, Live!

STAT

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

120
120
article thumbnail

Adverse events increased after hospitals acquired by private equity, study finds

Fierce Healthcare

A hospital’s acquisition by a private equity firm is linked to a rise in adverse events despite the pool of lower risk patients they tend to admit, according to a Medicare Part A claims analysis pu | Hospital-acquired adverse events among Medicare beneficiaries were 25% higher within the three years after a private equity acquisition compared to control (..)

Hospitals 136
article thumbnail

JP Morgan 2023 – Pre event

pharmaphorum

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday. The post JP Morgan 2023 – Pre event appeared first on. We’ll also wander over to the UC Davis Health Future & Health CEO Summit a little later this afternoon.

122
122